0000950170-24-096399.txt : 20240813
0000950170-24-096399.hdr.sgml : 20240813
20240813170003
ACCESSION NUMBER: 0000950170-24-096399
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240809
FILED AS OF DATE: 20240813
DATE AS OF CHANGE: 20240813
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Richards C Marc
CENTRAL INDEX KEY: 0001468881
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-12111
FILM NUMBER: 241202657
MAIL ADDRESS:
STREET 1: 7315 WISCONSIN AVENUE
STREET 2: SUITE 250-W
CITY: BETHESDA
STATE: MD
ZIP: 20814
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Pediatrix Medical Group, Inc.
CENTRAL INDEX KEY: 0000893949
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-HOSPITALS [8060]
ORGANIZATION NAME: 08 Industrial Applications and Services
IRS NUMBER: 263667538
STATE OF INCORPORATION: FL
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1301 CONCORD TERRACE
CITY: SUNRISE
STATE: FL
ZIP: 33323
BUSINESS PHONE: 9543840175
MAIL ADDRESS:
STREET 1: 1301 CONCORD TERRACE
CITY: SUNRISE
STATE: FL
ZIP: 33323
FORMER COMPANY:
FORMER CONFORMED NAME: MEDNAX, INC.
DATE OF NAME CHANGE: 20090102
FORMER COMPANY:
FORMER CONFORMED NAME: PEDIATRIX MEDICAL GROUP INC
DATE OF NAME CHANGE: 19950801
4
1
ownership.xml
4
X0508
4
2024-08-09
0000893949
Pediatrix Medical Group, Inc.
MD
0001468881
Richards C Marc
1301 CONCORD TERRACE
SUNRISE
FL
33323
false
true
false
false
EVP, Chief Financial Officer
false
Common Stock
2024-08-09
4
S
false
32562
10.08
D
192785
D
Common Stock
2024-08-12
4
S
false
17438
10.08
D
175347
D
The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions with prices randing from $10.01 to $10.23 for a weighted average sales price of $10.08. The reporting person undertakes to provide the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each seperate price within the range set forth in this footnote.
The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions with prices ranging from $10.00 to $10.17 for a weighted average sales price of $10.08. The reporting person undertakes to provide the issuer, any security holder of the issuer or the staff of the Securiites and Exchange Commission upon request, full information regarding the number of shares sold at each seperate price within the range set forth in this footnote.
/s/ Mary Ann E. Moore, Attorney-in-Fact
2024-08-13